Abstract

Tuberculous meningitis (TBM) is a frequent cause of meningitis in individuals with human immunodeficiency virus (HIV) infection, resulting in death in approximately 40% of affected patients. A severe complication of antiretroviral therapy (ART) in these patients is neurological tuberculosis–immune reconstitution inflammatory syndrome (IRIS), but its underlying cause remains poorly understood. To investigate the pathogenesis of TBM-IRIS, we performed longitudinal whole-blood microarray analysis of HIV-infected patients with TBM and reflected the findings at the protein level. Patients in whom TBM-IRIS eventually developed had significantly more abundant neutrophil-associated transcripts, from before development of TBM-IRIS through IRIS symptom onset. After ART initiation, a significantly higher abundance of transcripts associated with canonical and noncanonical inflammasomes was detected in patients with TBM-IRIS than in non-IRIS controls. Whole-blood transcriptome findings complement protein measurement from the site of disease, which together suggest a dominant role for the innate immune system in the pathogenesis of TBM-IRIS.

Highlights

  • Tuberculosis is the most common cause of death among persons with human immunodeficiency virus (HIV) type 1 infection [1]

  • Similar observations were reported from cerebrospinal fluid (CSF) in neurologically compartmentalized tuberculous meningitis (TBM)-immune reconstitution inflammatory syndrome (IRIS), with significantly higher concentrations of pro- and anti-inflammatory cytokines and chemokines were detected in patients who developed IRIS compared with those who did not [8]

  • We identified 327 differentially abundant (FC, >1.5: Q < 0.05) transcripts associated with TBM-IRIS (Figure 3A and Table S3) at 2 weeks after antiretroviral therapy (ART) initiation

Read more

Summary

Introduction

Tuberculosis is the most common cause of death among persons with human immunodeficiency virus (HIV) type 1 infection [1]. Longitudinal blood samples for RNA analysis were available for 33 of these patients (16 in the TBM-IRIS and 17 in the non-IRIS group) who were included in this study.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.